Intuitive Surgical Financial Statements (ISRG)
|
|
|
|
Report date
|
|
|
07.02.2020 |
10.02.2021 |
03.02.2022 |
10.02.2023 |
31.01.2024 |
|
18.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 479 |
4 358 |
5 710 |
6 222 |
7 124 |
|
7 867 |
|
Operating Income, bln rub |
|
|
1 375 |
773.6 |
1 821 |
1 211 |
1 767 |
|
2 064 |
|
EBITDA, bln rub |
? |
|
1 375 |
1 050 |
1 821 |
1 577 |
2 394 |
|
2 505 |
|
Net profit, bln rub |
? |
|
1 379 |
1 061 |
1 705 |
1 322 |
1 798 |
|
2 243 |
|
|
OCF, bln rub |
? |
|
1 598 |
1 485 |
2 089 |
1 491 |
1 814 |
|
1 594 |
|
CAPEX, bln rub |
? |
|
425.6 |
341.5 |
353.5 |
532.4 |
1 064 |
|
1 235 |
|
FCF, bln rub |
? |
|
1 173 |
1 143 |
1 736 |
958.4 |
749.6 |
|
359.4 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
8.00 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.36% |
|
|
OPEX, bln rub |
|
|
1 736 |
1 811 |
2 138 |
2 619 |
2 963 |
|
3 205 |
|
Cost of production, bln rub |
|
|
1 368 |
1 497 |
1 752 |
2 026 |
2 395 |
|
2 598 |
|
R&D, bln rub |
|
|
557.3 |
595.1 |
671.0 |
879.0 |
998.8 |
|
1 111 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
29.7 |
0.000 |
|
28.7 |
|
|
Assets, bln rub |
|
|
9 733 |
11 169 |
13 555 |
12 974 |
15 442 |
|
17 743 |
|
Net Assets, bln rub |
? |
|
8 285 |
9 759 |
11 952 |
11 113 |
13 308 |
|
15 583 |
|
Debt, bln rub |
|
|
76.4 |
79.9 |
87.0 |
93.8 |
89.8 |
|
0.000 |
|
Cash, bln rub |
|
|
5 845 |
6 869 |
8 620 |
6 742 |
5 223 |
|
4 232 |
|
Net debt, bln rub |
|
|
-5 769 |
-6 789 |
-8 533 |
-6 648 |
-5 133 |
|
-4 232 |
|
|
Ordinary share price, rub |
|
|
197.1 |
272.7 |
359.3 |
265.4 |
337.4 |
|
278.5 |
|
Number of ordinary shares, mln |
|
|
346.2 |
351.0 |
356.1 |
355.7 |
351.2 |
|
355.8 |
|
|
Market cap, bln rub |
|
|
68 219 |
95 718 |
127 947 |
94 385 |
118 481 |
|
99 076 |
|
EV, bln rub |
? |
|
62 450 |
88 929 |
119 414 |
87 737 |
113 347 |
|
94 844 |
|
Book value, bln rub |
|
|
7 865 |
9 345 |
11 537 |
10 714 |
12 920 |
|
15 210 |
|
|
EPS, rub |
? |
|
3.98 |
3.02 |
4.79 |
3.72 |
5.12 |
|
6.30 |
|
FCF/share, rub |
|
|
3.39 |
3.26 |
4.87 |
2.69 |
2.13 |
|
1.01 |
|
BV/share, rub |
|
|
22.7 |
26.6 |
32.4 |
30.1 |
36.8 |
|
42.7 |
|
|
EBITDA margin, % |
? |
|
30.7% |
24.1% |
31.9% |
25.3% |
33.6% |
|
31.8% |
|
Net margin, % |
? |
|
30.8% |
24.3% |
29.9% |
21.3% |
25.2% |
|
28.5% |
|
FCF yield, % |
? |
|
1.72% |
1.19% |
1.36% |
1.02% |
0.63% |
|
0.36% |
|
ROE, % |
? |
|
16.6% |
10.9% |
14.3% |
11.9% |
13.5% |
|
14.4% |
|
ROA, % |
? |
|
14.2% |
9.50% |
12.6% |
10.2% |
11.6% |
|
12.6% |
|
|
P/E |
? |
|
49.5 |
90.2 |
75.1 |
71.4 |
65.9 |
|
44.2 |
|
P/FCF |
|
|
58.2 |
83.7 |
73.7 |
98.5 |
158.1 |
|
275.7 |
|
P/S |
? |
|
15.2 |
22.0 |
22.4 |
15.2 |
16.6 |
|
12.6 |
|
P/BV |
? |
|
8.67 |
10.2 |
11.1 |
8.81 |
9.17 |
|
6.51 |
|
EV/EBITDA |
? |
|
45.4 |
84.7 |
65.6 |
55.6 |
47.3 |
|
37.9 |
|
Debt/EBITDA |
|
|
-4.20 |
-6.47 |
-4.69 |
-4.22 |
-2.14 |
|
-1.69 |
|
|
R&D/CAPEX, % |
|
|
130.9% |
174.3% |
189.8% |
165.1% |
93.9% |
|
90.0% |
|
|
CAPEX/Revenue, % |
|
|
9.50% |
7.84% |
6.19% |
8.56% |
14.9% |
|
15.7% |
|
| Intuitive Surgical shareholders |
